| Year |
Citation |
Score |
| 2024 |
Ayten M, Díaz-Lezama N, Ghanawi H, Haffelder FC, Kajtna J, Straub T, Borso M, Imhof A, Hauck SM, Koch SF. Metabolic plasticity in a Pde6b retinitis pigmentosa mouse model following rescue. Molecular Metabolism. 101994. PMID 39032643 DOI: 10.1016/j.molmet.2024.101994 |
0.312 |
|
| 2023 |
Jentzsch MC, Tsang SH, Koch SF. A New Preclinical Model of Retinitis Pigmentosa Due to Deficiency. Ophthalmology Science. 3: 100332. PMID 37363133 DOI: 10.1016/j.xops.2023.100332 |
0.457 |
|
| 2023 |
Díaz-Lezama N, Kajtna J, Wu J, Ayten M, Koch SF. Microglial and macroglial dynamics in a model of retinitis pigmentosa. Vision Research. 210: 108268. PMID 37295269 DOI: 10.1016/j.visres.2023.108268 |
0.303 |
|
| 2022 |
Kajtna J, Tsang SH, Koch SF. Late-stage rescue of visually guided behavior in the context of a significantly remodeled retinitis pigmentosa mouse model. Cellular and Molecular Life Sciences : Cmls. 79: 148. PMID 35195763 DOI: 10.1007/s00018-022-04161-0 |
0.466 |
|
| 2019 |
Wert KJ, Koch SF, Velez G, Hsu CW, Mahajan M, Bassuk AG, Tsang SH, Mahajan VB. CAPN5 genetic inactivation phenotype supports therapeutic inhibition trials. Human Mutation. PMID 31403230 DOI: 10.1002/Humu.23894 |
0.615 |
|
| 2019 |
Sancho-Pelluz J, Cui X, Lee W, Tsai YT, Wu WH, Justus S, Washington I, Hsu CW, Park KS, Koch S, Velez G, Bassuk AG, Mahajan VB, Lin CS, Tsang SH. Mechanisms of neurodegeneration in a preclinical autosomal dominant retinitis pigmentosa knock-in model with a Rho mutation. Cellular and Molecular Life Sciences : Cmls. PMID 30976840 DOI: 10.1007/S00018-019-03090-9 |
0.481 |
|
| 2018 |
Koch SF, Tsang SH. Success of Gene Therapy in Late-Stage Treatment. Advances in Experimental Medicine and Biology. 1074: 101-107. PMID 29721933 DOI: 10.1007/978-3-319-75402-4_13 |
0.444 |
|
| 2017 |
Koch SF, Duong JK, Hsu CW, Tsai YT, Lin CS, Wahl-Schott CA, Tsang SH. Genetic rescue models refute nonautonomous rod cell death in retinitis pigmentosa. Proceedings of the National Academy of Sciences of the United States of America. PMID 28468800 DOI: 10.1073/Pnas.1615394114 |
0.45 |
|
| 2017 |
Michalakis S, Shaltiel L, Sothilingam V, Koch S, Schludi V, Krause S, Zeitz C, Audo I, Lancelot ME, Hamel C, Meunier I, Preising MN, Friedburg C, Lorenz B, Zabouri N, et al. Mosaic synaptopathy and functional defects in Cav1.4 heterozygous mice and human carriers of CSNB2. Human Molecular Genetics. 26: 466. PMID 28365780 DOI: 10.1093/Hmg/Ddw424 |
0.328 |
|
| 2016 |
Schön C, Asteriti S, Koch S, Sothilingam V, Garcia Garrido M, Tanimoto N, Herms J, Seeliger MW, Cangiano L, Biel M, Michalakis S. Loss of HCN1 enhances disease progression in mouse models of CNG channel-linked retinitis pigmentosa and achromatopsia. Human Molecular Genetics. PMID 26740549 DOI: 10.1093/Hmg/Ddv639 |
0.432 |
|
| 2015 |
Koch SF, Tsai YT, Duong JK, Wu WH, Hsu CW, Wu WP, Bonet-Ponce L, Lin CS, Tsang SH. Halting progressive neurodegeneration in advanced retinitis pigmentosa. The Journal of Clinical Investigation. 125: 3704-13. PMID 26301813 DOI: 10.1172/Jci82462 |
0.47 |
|
| 2014 |
Arango-Gonzalez B, Trifunović D, Sahaboglu A, Kranz K, Michalakis S, Farinelli P, Koch S, Koch F, Cottet S, Janssen-Bienhold U, Dedek K, Biel M, Zrenner E, Euler T, Ekström P, et al. Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration. Plos One. 9: e112142. PMID 25392995 DOI: 10.1371/Journal.Pone.0112142 |
0.364 |
|
| 2014 |
Michalakis S, Koch S, Sothilingam V, Garrido MG, Tanimoto N, Schulze E, Becirovic E, Koch F, Seide C, Beck SC, Seeliger MW, Mühlfriedel R, Biel M. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa. Advances in Experimental Medicine and Biology. 801: 733-9. PMID 24664765 DOI: 10.1007/978-1-4614-3209-8_92 |
0.334 |
|
| 2014 |
Michalakis S, Shaltiel L, Sothilingam V, Koch S, Schludi V, Krause S, Zeitz C, Audo I, Lancelot ME, Hamel C, Meunier I, Preising MN, Friedburg C, Lorenz B, Zabouri N, et al. Mosaic synaptopathy and functional defects in Cav1.4 heterozygous mice and human carriers of CSNB2. Human Molecular Genetics. 23: 1538-50. PMID 24163243 DOI: 10.1093/Hmg/Ddt541 |
0.397 |
|
| 2013 |
Michalakis S, Schäferhoff K, Spiwoks-Becker I, Zabouri N, Koch S, Koch F, Bonin M, Biel M, Haverkamp S. Characterization of neurite outgrowth and ectopic synaptogenesis in response to photoreceptor dysfunction. Cellular and Molecular Life Sciences : Cmls. 70: 1831-47. PMID 23269435 DOI: 10.1007/S00018-012-1230-Z |
0.348 |
|
| 2012 |
Koch S, Sothilingam V, Garcia Garrido M, Tanimoto N, Becirovic E, Koch F, Seide C, Beck SC, Seeliger MW, Biel M, Mühlfriedel R, Michalakis S. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa. Human Molecular Genetics. 21: 4486-96. PMID 22802073 DOI: 10.1093/Hmg/Dds290 |
0.43 |
|
| 2012 |
Michalakis S, Mühlfriedel R, Tanimoto N, Krishnamoorthy V, Koch S, Fischer MD, Becirovic E, Bai L, Huber G, Beck SC, Fahl E, Büning H, Schmidt J, Zong X, Gollisch T, et al. Gene therapy restores missing cone-mediated vision in the CNGA3-/- mouse model of achromatopsia. Advances in Experimental Medicine and Biology. 723: 183-9. PMID 22183332 DOI: 10.1007/978-1-4614-0631-0_25 |
0.432 |
|
| 2012 |
Shaltiel L, Michalakis S, Sothilingam V, Garrido MG, Koch S, Tanimoto N, Seeliger MW, Biel M, Wahl-Schott CA. Visual Function in CaV1.4-Deficient Mice Biophysical Journal. 102: 1-7. DOI: 10.1016/J.Bpj.2011.11.706 |
0.401 |
|
| 2010 |
Michalakis S, Mühlfriedel R, Tanimoto N, Krishnamoorthy V, Koch S, Fischer MD, Becirovic E, Bai L, Huber G, Beck SC, Fahl E, Büning H, Paquet-Durand F, Zong X, Gollisch T, et al. Restoration of cone vision in the CNGA3-/- mouse model of congenital complete lack of cone photoreceptor function. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 2057-63. PMID 20628362 DOI: 10.1038/Mt.2010.149 |
0.424 |
|
| Show low-probability matches. |